Assignee
GUANGZHOU SINOGEN PHARMACEUTICAL CO LTD
CN·4 granted patents·1 pending application·0 citations·filing 2017–2020
Top patents by PatentIndex Score
5 records- 0161US11318172B2Use of genetically engineered bacterium of attenuated Salmonella typhimurium in for treating liver cancerGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2020·Granted May 3, 2022·0 cites·5 claims
- 0253US11771721B2Applications of genetically engineered bacteria VNP20009-M in preparation of drugs for preventing and treating lung cancerGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 3, 2023·0 cites·11 claims
- 0347US2023250451A1Application of methioninase gene therapy in treatment of malignant tumorGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0446US12478664B2Use of genetically engineered strain VNP20009-M in preventing and treating cancer metastasisGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 25, 2025·0 cites·6 claims
- 0544US11324781B2Application of genetically engineered bacteria VNP20009-M in preparing drug for treating malignant sarcomaGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2018·Granted May 10, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when GUANGZHOU SINOGEN PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →